Preventing Heart Attacks with seaweed gel

October 4, 2009

Animal model experiments revealed that some 90% of animals treated with the gel survived a heart attack, while among those untreated only 40% survived. The latest trial is a clinical trial consisting of 23 patients in Germany and Belgium. “They are doing fine,” says company representative Dganit Bar. Toxicity tests have shown the product is safe.

Based on a common brown seaweed with other active ingredients, Bar believes that the product could see very swift development, as early as 2012. The quick time to market has to do with the fact that it is being marketed as a medical device and not a drug, says Bar. For more information: [email protected], 972-2-548-9100.

Excerpts from an article by Karin Kloosterman, www.israel21c.org

Photo Credit: